UP
koKRtier 1 1분
[안트로젠] 투자판단관련주요경영사항(임상시험계획승인신청) (ANT-301 국내 제2상 임상시험 계획 승인신청)
No RSS summary is available. Open the original link to read more.
Company
안트로젠· 065660
ANTEROGEN CO., LTD.
Showing 4 RSS articles and DART filings mapped to this company, sorted by time.
- Market
- LISTED
- Items
- 4
Recent news & filings
UP
koKRtier 1 1분
[안트로젠] 투자판단관련주요경영사항(임상시험계획변경승인신청) (이영양성 수포성 표피박리증(DEB)의 미국 FDA 2상 임상시험계획 변경승인신청)
No RSS summary is available. Open the original link to read more.
UP
koKRtier 1 1분
[안트로젠] 반기보고서 (2026.06)
No RSS summary is available. Open the original link to read more.
UP
koKRtier 1 1분
[안트로젠] 투자판단관련주요경영사항(임상시험결과) (ANT-301-102 1상 임상시험의 Top-line data 수령)
No RSS summary is available. Open the original link to read more.